BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15908686)

  • 1. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?
    Wieand HS
    J Clin Oncol; 2005 May; 23(15):3643-4; author reply 3646-8. PubMed ID: 15908687
    [No Abstract]   [Full Text] [Related]  

  • 3. Resisting a fundamentalist policy.
    Castro M
    J Clin Oncol; 2005 May; 23(15):3645-6; author reply 3646-8. PubMed ID: 15908688
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical guidelines for diagnostic use of in vitro chemosensitivity tests.
    Schinköthe T; Haeger S; Gabri MR
    Anticancer Res; 2007; 27(3A):1365-7. PubMed ID: 17593632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
    Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
    J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity testing: a critical review.
    Cramer AB; Woltering EA
    Crit Rev Clin Lab Sci; 1991; 28(5-6):405-13. PubMed ID: 1772587
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro testing for drug resistance and drug sensitivity in clinical oncology].
    Kiss I; Zaloudík J; Vyzula R; Tomásek J; Maláska J; Coufal O; Kocáková I
    Vnitr Lek; 2001 Sep; 47(9):621-6. PubMed ID: 11715667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening finds potential killer of cancer stem cells.
    Rowan K
    J Natl Cancer Inst; 2009 Nov; 101(21):1438-9. PubMed ID: 19828869
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of chemosensitivity testing.
    Blumenthal RD
    Methods Mol Med; 2005; 110():3-18. PubMed ID: 15901922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress of individualized chemotherapy guided by chemosensitivity test].
    Mi YJ; Zhang CZ; Fu LW
    Yao Xue Xue Bao; 2009 Nov; 44(11):1187-92. PubMed ID: 21355317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of chemosensitivity testing.
    Hwu P; Bedikian AY; Grimm EA
    Clin Cancer Res; 2006 Sep; 12(18):5258-9. PubMed ID: 17000655
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro testing of chemosensitivity in physiological hypoxia.
    Grigoryan R; Keshelava N; Anderson C; Reynolds CP
    Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemosensitivity test of breast cancer].
    Oura S; Tanino H; Naito Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
    [No Abstract]   [Full Text] [Related]  

  • 15. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemosensitivity test-based chemotherapy for brain tumors].
    Fujimoto S
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():456-9. PubMed ID: 16201564
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview: the art of cancer drug screening: molecular target versus milieu-based screens.
    Sawyers CL; Sausville EA
    Curr Opin Investig Drugs; 2002 Mar; 3(3):478-81. PubMed ID: 12054100
    [No Abstract]   [Full Text] [Related]  

  • 18. New anticancer agents: in vitro and in vivo evaluation.
    Zips D; Thames HD; Baumann M
    In Vivo; 2005; 19(1):1-7. PubMed ID: 15796152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of random screening of antineoplastic agents in Japan. The sixth report].
    Gan To Kagaku Ryoho; 1994 Jul; 21(9):1301-556. PubMed ID: 8067784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.